Signal or noise? > Who Should Track Gene Therapy Outcomes Long Term? ASTCT
Panel Debates Shared Responsibility - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #biotech #competitivemarketing
Panel Debates Shared Responsibility - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #biotech #competitivemarketing
Who Should Track Gene Therapy Outcomes Long Term? ASTCT
Panel Debates Shared Responsibility - Pharmacy Times
Who Should Track Gene Therapy Outcomes Long Term? ASTCT Panel Debates Shared Responsibility Pharmacy Times
dlvr.it
November 6, 2026 at 9:24 PM
Signal or noise? > Who Should Track Gene Therapy Outcomes Long Term? ASTCT
Panel Debates Shared Responsibility - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #biotech #competitivemarketing
Panel Debates Shared Responsibility - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #biotech #competitivemarketing
Signal or noise? > Gene Therapy Requires More Than an Infusion: ASTCT Experts
Detail Hidden Barriers to Care - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #pharma #biotech #healthcare #competitivemarketing #pharmaceutical
Detail Hidden Barriers to Care - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #pharma #biotech #healthcare #competitivemarketing #pharmaceutical
Gene Therapy Requires More Than an Infusion: ASTCT Experts
Detail Hidden Barriers to Care - Pharmacy Times
Gene Therapy Requires More Than an Infusion: ASTCT Experts Detail Hidden Barriers to Care Pharmacy Times
dlvr.it
November 5, 2026 at 7:24 PM
Signal or noise? > Gene Therapy Requires More Than an Infusion: ASTCT Experts
Detail Hidden Barriers to Care - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #pharma #biotech #healthcare #competitivemarketing #pharmaceutical
Detail Hidden Barriers to Care - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #pharma #biotech #healthcare #competitivemarketing #pharmaceutical
Signal or noise? > Why Ultra-Rare Gene Therapies Struggle to Reach Patients:
Lessons From DBA at ASTCT - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #competitivemarketing #pharma #biotech
Lessons From DBA at ASTCT - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #competitivemarketing #pharma #biotech
Why Ultra-Rare Gene Therapies Struggle to Reach Patients:
Lessons From DBA at ASTCT - Pharmacy Times
Why Ultra-Rare Gene Therapies Struggle to Reach Patients: Lessons From DBA at ASTCT Pharmacy Times
dlvr.it
November 5, 2026 at 4:24 PM
Signal or noise? > Why Ultra-Rare Gene Therapies Struggle to Reach Patients:
Lessons From DBA at ASTCT - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #competitivemarketing #pharma #biotech
Lessons From DBA at ASTCT - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #competitivemarketing #pharma #biotech
Hospital dance videos. Walks to photograph flowers. Songs to share with Ron.
Meet Cynthia Paine, our October Survivor Spotlight, who received a transplant for AML in 2021.
bmtinfonet.org/story/acute-...
Thanks to Colorado Blood Cancer Institute, ASTCT, and Sanofi
Meet Cynthia Paine, our October Survivor Spotlight, who received a transplant for AML in 2021.
bmtinfonet.org/story/acute-...
Thanks to Colorado Blood Cancer Institute, ASTCT, and Sanofi
October 9, 2026 at 6:42 PM
Hospital dance videos. Walks to photograph flowers. Songs to share with Ron.
Meet Cynthia Paine, our October Survivor Spotlight, who received a transplant for AML in 2021.
bmtinfonet.org/story/acute-...
Thanks to Colorado Blood Cancer Institute, ASTCT, and Sanofi
Meet Cynthia Paine, our October Survivor Spotlight, who received a transplant for AML in 2021.
bmtinfonet.org/story/acute-...
Thanks to Colorado Blood Cancer Institute, ASTCT, and Sanofi
📢 #Tandem27 registration is open!
Join ASTCT and CIBMTR for the latest research, emerging therapies, and advances in transplantation and cellular therapy.
📍 Orlando, FL | 📅 Feb. 17-20, 2027
Register: www.tandemmeetings.com/Registration...
Join ASTCT and CIBMTR for the latest research, emerging therapies, and advances in transplantation and cellular therapy.
📍 Orlando, FL | 📅 Feb. 17-20, 2027
Register: www.tandemmeetings.com/Registration...
October 7, 2026 at 6:39 PM
📢 #Tandem27 registration is open!
Join ASTCT and CIBMTR for the latest research, emerging therapies, and advances in transplantation and cellular therapy.
📍 Orlando, FL | 📅 Feb. 17-20, 2027
Register: www.tandemmeetings.com/Registration...
Join ASTCT and CIBMTR for the latest research, emerging therapies, and advances in transplantation and cellular therapy.
📍 Orlando, FL | 📅 Feb. 17-20, 2027
Register: www.tandemmeetings.com/Registration...
Abstract submission for #Tandem27 is now open! ASTCT and CIBMTR invite you to share your research with your HCT, cell, and gene therapy colleagues in Orlando, FL, February 17-20, 2027! Learn more: www.tandemmeetings.com/Abstracts/Ab...
@astct.bsky.social
@astct.bsky.social
September 25, 2026 at 4:00 PM
Abstract submission for #Tandem27 is now open! ASTCT and CIBMTR invite you to share your research with your HCT, cell, and gene therapy colleagues in Orlando, FL, February 17-20, 2027! Learn more: www.tandemmeetings.com/Abstracts/Ab...
@astct.bsky.social
@astct.bsky.social
The wait is over. Registration for #Tandem27 is officially open!
Join ASTCT and CIBMTR in Orlando, February 17-20, 2027, for the premier event in HCT, cellular therapy, and gene therapy.
📍 Orlando, FL
📅 February 17-20, 2027
Secure your spot today: www.tandemmeetings.com/Registration...
Join ASTCT and CIBMTR in Orlando, February 17-20, 2027, for the premier event in HCT, cellular therapy, and gene therapy.
📍 Orlando, FL
📅 February 17-20, 2027
Secure your spot today: www.tandemmeetings.com/Registration...
September 16, 2026 at 8:33 PM
The wait is over. Registration for #Tandem27 is officially open!
Join ASTCT and CIBMTR in Orlando, February 17-20, 2027, for the premier event in HCT, cellular therapy, and gene therapy.
📍 Orlando, FL
📅 February 17-20, 2027
Secure your spot today: www.tandemmeetings.com/Registration...
Join ASTCT and CIBMTR in Orlando, February 17-20, 2027, for the premier event in HCT, cellular therapy, and gene therapy.
📍 Orlando, FL
📅 February 17-20, 2027
Secure your spot today: www.tandemmeetings.com/Registration...
Miguel-Angel Perales, Jorg Dietrich, Juliane Gust, Bianca Santomasso, Kai Rejeski, Doris Hansen, Nirali N Shah, Jesus Berdeja, Michael Bishop, Eric Bleickardt, Jennifer Brudno, Saurabh Dahiya, Noelle Frey, Matthew J Frigault, Rebecca Gardner, Armin Ghobadi, Stephan Grupp, Mehdi Hamadani, et al.
ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy
In 2019, the American Society for Transplantation and Cellular Therapy (ASTCT) developed consensus definitions and grading criteria for the common immune effector cell (IEC)-associated toxicities of cytokine release syndrome (CRS) and IEC-associated neurotoxicity syndrome (ICANS). These grading scales were widely adopted by clinicians, investigators, and sponsors, allowing a clearer understanding of outcomes across clinical trials and a uniform basis to inform treatment algorithms. Since then,...
linkinghub.elsevier.com
September 9, 2026 at 4:00 AM
Miguel-Angel Perales, Jorg Dietrich, Juliane Gust, Bianca Santomasso, Kai Rejeski, Doris Hansen, Nirali N Shah, Jesus Berdeja, Michael Bishop, Eric Bleickardt, Jennifer Brudno, Saurabh Dahiya, Noelle Frey, Matthew J Frigault, Rebecca Gardner, Armin Ghobadi, Stephan Grupp, Mehdi Hamadani, et al.
Abstract submission for #Tandem27 is now open! ASTCT and CIBMTR invite you to share your research with your HCT, cell, and gene therapy colleagues in Orlando, FL, February 17-20, 2027! Learn more www.tandemmeetings.com/Abstr.../Abs...
@astct.bsky.social
@astct.bsky.social
September 2, 2026 at 6:00 PM
Abstract submission for #Tandem27 is now open! ASTCT and CIBMTR invite you to share your research with your HCT, cell, and gene therapy colleagues in Orlando, FL, February 17-20, 2027! Learn more www.tandemmeetings.com/Abstr.../Abs...
@astct.bsky.social
@astct.bsky.social
Abstract submission for #Tandem27 is now open! ASTCT and CIBMTR invite you to share your research with your HCT, cell, and gene therapy colleagues in Orlando, FL, February 17-20, 2027! Learn more www.tandemmeetings.com/Abstr.../Abs...
@astct.bsky.social
@astct.bsky.social
August 21, 2026 at 3:30 PM
Abstract submission for #Tandem27 is now open! ASTCT and CIBMTR invite you to share your research with your HCT, cell, and gene therapy colleagues in Orlando, FL, February 17-20, 2027! Learn more www.tandemmeetings.com/Abstr.../Abs...
@astct.bsky.social
@astct.bsky.social
Elevate your expertise in transplantation, cell, and gene therapy from discovery to delivery at #Tandem26. Join us in February 2026 in Salt Lake City to explore breakthroughs, connect with leaders, and move the field forward. www.youtube.com/watch?v=vqnd...
Elevate Your Expertise at the 2026 Tandem Meetings
YouTube video by ASTCT
www.youtube.com
November 12, 2025 at 8:51 PM
Elevate your expertise in transplantation, cell, and gene therapy from discovery to delivery at #Tandem26. Join us in February 2026 in Salt Lake City to explore breakthroughs, connect with leaders, and move the field forward. www.youtube.com/watch?v=vqnd...
Abstract submission for #Tandem26 is now open! ASTCT and CIBMTR invite you to share your research with 5,000+ HCT, cell, and gene therapy colleagues in Salt Lake City, UT, February 4-7, 2026! Learn more and submit an abstract at www.tandemmeetings.com/Abstracts/Ab...
August 26, 2025 at 6:42 PM
Abstract submission for #Tandem26 is now open! ASTCT and CIBMTR invite you to share your research with 5,000+ HCT, cell, and gene therapy colleagues in Salt Lake City, UT, February 4-7, 2026! Learn more and submit an abstract at www.tandemmeetings.com/Abstracts/Ab...
Speechless and beyond grateful to honor the journey of Dr. Wartman as the ASTCT 2025 Lukas D. Wartman #GVHD Achievement Awardee. Thank you to my patients for constant inspiration and colleagues for encouragement over the years. What unexpected recognition. I share this award with you! ❤️🙏
February 15, 2025 at 9:57 AM
Speechless and beyond grateful to honor the journey of Dr. Wartman as the ASTCT 2025 Lukas D. Wartman #GVHD Achievement Awardee. Thank you to my patients for constant inspiration and colleagues for encouragement over the years. What unexpected recognition. I share this award with you! ❤️🙏
What clinical factors impact the likelihood of a patient receiving an allogeneic transplant? @msorror @ASTCT #ToxicitiesConference24
November 16, 2024 at 5:05 PM
What clinical factors impact the likelihood of a patient receiving an allogeneic transplant? @msorror @ASTCT #ToxicitiesConference24
Scope of the ASTCT Toxicities Conference over the years, Dr. Michael Scordo from MSKCC:
November 16, 2024 at 4:33 PM
Scope of the ASTCT Toxicities Conference over the years, Dr. Michael Scordo from MSKCC:
Impressive response data for #TIL in #NSCLC @DrBetofMDPhD @ASTCT #ToxicitiesConference24 Next, can we eliminate IL-2? 🧯🔥
November 16, 2024 at 3:43 PM
Impressive response data for #TIL in #NSCLC @DrBetofMDPhD @ASTCT #ToxicitiesConference24 Next, can we eliminate IL-2? 🧯🔥
Dr. Reena Thomas from Stanford - TIAN: Tumor inflammation-associated neurotoxicity, observed in CAR T cell therapy for GBM 🧠, distinct from ICANS due to neuroanatomical region specificity @ASTCT #ToxicitiesConference24
November 16, 2024 at 3:05 PM
Dr. Reena Thomas from Stanford - TIAN: Tumor inflammation-associated neurotoxicity, observed in CAR T cell therapy for GBM 🧠, distinct from ICANS due to neuroanatomical region specificity @ASTCT #ToxicitiesConference24
Here we go! @BrianShafferMD leading us through the morning session addressing controversies re: #PTCy. Dose? Alternatives? Toxicities? @ASTCT #ToxicitiesConference24
November 16, 2024 at 1:23 PM
Here we go! @BrianShafferMD leading us through the morning session addressing controversies re: #PTCy. Dose? Alternatives? Toxicities? @ASTCT #ToxicitiesConference24
What will change in administration to #POTUS47 mean for #telemedicine 💻coverage in 2025? Dr. Sarah Wall from OSU is asking the tough questions.🤔
@ASTCT
#ToxicitiesConference24 Will common sense prevail?
@ASTCT
#ToxicitiesConference24 Will common sense prevail?
November 15, 2024 at 9:55 PM
What will change in administration to #POTUS47 mean for #telemedicine 💻coverage in 2025? Dr. Sarah Wall from OSU is asking the tough questions.🤔
@ASTCT
#ToxicitiesConference24 Will common sense prevail?
@ASTCT
#ToxicitiesConference24 Will common sense prevail?
~50% subsequent admission rate for initial grade 1 outpatient CRS management - Mayo experience presented by Dr. Yi Lin. #ASTCT #ToxicitiesConference24
November 15, 2024 at 9:11 PM
~50% subsequent admission rate for initial grade 1 outpatient CRS management - Mayo experience presented by Dr. Yi Lin. #ASTCT #ToxicitiesConference24
👂 @GiraltSergio : ~1/4 of people with #myeloma do not hear about transplant from a transplant physician. @ASTCT #Toxicities All patients should be able to access a transplant expert to hear the pros/cons.
November 15, 2024 at 3:53 PM
👂 @GiraltSergio : ~1/4 of people with #myeloma do not hear about transplant from a transplant physician. @ASTCT #Toxicities All patients should be able to access a transplant expert to hear the pros/cons.
My favorite meeting -- the ASTCT Toxicities Conference - is underway! Nice virtual platform:
November 15, 2024 at 2:26 PM
My favorite meeting -- the ASTCT Toxicities Conference - is underway! Nice virtual platform:
🚀 Excited for the next episode of @ASTCT #ASTCTTalks "Titans of Transplant"! Join my conversation with Dr. Renier Brentjens, a trailblazer in CAR T-cell therapy. Learn about the CAR T journey from the very beginning. 🎧 Don't miss this inspiring discussion! www.astct.org/Nucleus/Arti...
ASTCT Talks: Titans of Transplant: Dr. Renier Brentjens
In the next episode of ASTCT's "Titans of Transplant," Dr. Shernan Holtan hosts Dr. Renier Brentjens, a pioneer in CAR T-cell therapy and a transformative leader in transplantation and cellular therap...
www.astct.org
November 12, 2024 at 10:13 PM
🚀 Excited for the next episode of @ASTCT #ASTCTTalks "Titans of Transplant"! Join my conversation with Dr. Renier Brentjens, a trailblazer in CAR T-cell therapy. Learn about the CAR T journey from the very beginning. 🎧 Don't miss this inspiring discussion! www.astct.org/Nucleus/Arti...
Stay current on emerging evidence in transplantation and cellular therapy.
At next week's ASTCT Pharmacy Journal Club, presenters will review data from the ATLAS trial and ZUMA-2 Cohort 3.
Register: learn.astct.org/products/ast...
At next week's ASTCT Pharmacy Journal Club, presenters will review data from the ATLAS trial and ZUMA-2 Cohort 3.
Register: learn.astct.org/products/ast...
June 3, 2026 at 1:31 AM
Stay current on emerging evidence in transplantation and cellular therapy.
At next week's ASTCT Pharmacy Journal Club, presenters will review data from the ATLAS trial and ZUMA-2 Cohort 3.
Register: learn.astct.org/products/ast...
At next week's ASTCT Pharmacy Journal Club, presenters will review data from the ATLAS trial and ZUMA-2 Cohort 3.
Register: learn.astct.org/products/ast...